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In 2010 (as of 13 October 2010), the number of adeno-
virus conjunctivitis cases reported to the Robert Koch 
Institute in Berlin, Germany, has increased by more 
than 250% compared with same period in the previous 
two years. An investigation was initiated to identify 
spatial or temporal clusters, possible sources of infec-
tion and potential connections to cases abroad. The 
analysis did not show a disproportionately affected 
sex or age group, but many infections were preceded 
by exposure to ophthalmological facilities, communal 
facilities or public places.
Background
Several reports have recently been posted in ProMED 
of viral conjunctivitis in various parts of the world [1-7]. 
Since the beginning of 2010, there has been a rise in 
the number of notified cases of adenovirus conjunc-
tivitis in several German Laender. The Robert Koch 
Institute (RKI) in Berlin initiated an investigation of all 
notified cases in the country in order to identify spatial 
or temporal clusters of cases, any potential connec-
tion to cases abroad and possible sources of infection, 
so that appropriate public health measures could be 
recommended.
Adenoviruses are non-enveloped double-stranded 
DNA-viruses, which are resistant to various treat-
ments (e.g. extremes of pH) and are therefore difficult 
to inactivate. They can be transmitted via contami-
nated hands or objects, often in healthcare settings. 
Depending on the serotype, clinical manifestations are 
related to different organ systems, such as the eye and 
the respiratory or gastrointestinal tract, resulting in 
diverse clinical pictures. The most frequently detected 
human adenoviruses (HAdV) found in conjunctivitis are 
of serotypes 8, 19 and 37 [8].
Adenovirus conjunctivitis is characterised by sudden 
onset of symptoms and can be diagnosed clinically by 
keratitis with coin-shaped infiltrations in the cornea. It 
is usually self-limiting. The incubation period generally 
lasts from five to 12 days and the person remains infec-
tive for up to three weeks. Diagnosis can be labora-
tory confirmed by direct detection of the pathogen (by 
polymerase chain reaction (PCR), immunoassays or cell 
culture). As only the symptoms can be treated, good 
hygiene and disinfection management are therefore 
important for prevention and control of the disease 
[9,10].
Case notification
In Germany, notification to local health authorities is 
mandatory for laboratories that detect adenoviruses 
from conjunctival swabs (direct detection of antigen or 
DNA) [11]. Case data, including data on epidemiological 
links, is then reported to Robert Koch Institute accord-
ing to the national case definition. The German notifi-
cation system has been described previously [12].
Notified cases in 2010 (up to 13 October 2010) in 
Germany were analysed and compared with the two 
previous years regarding temporal and spatial distribu-
tion. Clusters were defined as epidemiologically linked 
cases with a minimum of two persons, whereas spo-
radic cases had no documented link to other cases.
We asked all cases notified from weeks 34 to 40 (i.e. 
over the previous six weeks) from six Laender whether 
they would be prepared to be interviewed, using an 
exploratory questionnaire, in order to generate a 
hypothesis of common infection modes or sources. 
Selecting weeks 34 to 40 allowed us to obtain a suf-
ficiently large sample size and given the cases were 
recent, recall bias was minimised.
Analysis of notified cases
As of 13 October 2010, 370 persons with adenovirus 
conjunctivitis with onset of symptoms from 1 January 
2010 were notified to local health authorities and 
reported to the Robert Koch Institute. The date of 
symptom onset was recorded for 303, while in a further 
67 cases it was assumed to be in 2010 due to the time 
2 www.eurosurveillance.org
of notification. During the same time period in 2008 
and 2009, 141 and 134 cases respectively were notified 
(the total number of notified cases was 180 in 2008 
and 169 in 2009). In those years, the infections were 
distributed widely, affecting urban and rural districts, 
with the highest number of cases occurring in August. 
In 2010, the median and mean age of cases was 39 years 
(range: 0–90 years). A total of 186 (50%) were men (in 
2008: 47%; in 2009: 51%). Cases were notified in all 
Laender, from laboratories to local health authorities 
in 121 rural and urban districts (30% of all districts). 
Cases were mainly clustered in northern Germany 
(whereas in 2009, they were more evenly distributed). 
The highest incidence was found in Mecklenburg-West-
Pomerania (in the north-east of the country) with five 
cases per 100,000 population (Figure 1, Table 1). The 
highest number of cases was reported in week 13 (the 
week before Easter) (Figure 2). The appearance of cases 
in the same region within a four-week period suggests 
a common source of infection or related cause.
Country of infection was reported in 301 (81%) cases 
in 2010: Germany was most frequently mentioned 
(n=292), followed by Thailand (n=3), Egypt (n=1), India 
(n=1), Portugal (n=1), Romania (n=1), Russia (n=1) and 
Switzerland (n=1). Serotypes of 15 samples were avail-
able: HAdV-8 (n=7), HAdV-37 (n=4), HAdV-19 (n=3) and 
one case of HAdV-3, a serotype usually associated with 
respiratory infections [13].
Cluster cases
In 2010, 120 (32%) of the 370 cases were linked to 22 
clusters (in 2008, there were 46 cases (33%) in 10 clus-
ters; in 2009, there were 25 cases (15%) in nine clus-
ters). The 2010 clusters were located across 16 rural 
and urban districts in eight Laender. The proportion 
of cases linked to clusters decreased around week 19 
(Figure 2). The median age of cases in clusters was 32 
years (mean: 33 years, range: 0–90).
Sporadic cases
There were 250 (67.6%) sporadic cases, of whom 133 
were men. The median age was 43 years (mean: 42 
years, range: 0–89). Approximately 40% of all spo-
radic cases appeared in locations close to clustered 
cases, which points to a possible connection. However, 
some sporadic cases were geographically isolated, in 
regions far from the clusters (Figure 1). 
Most clusters were notified as being associated with 
ophthalmological facilities or hospitals. Some were 
related to outbreaks in child day-care centres or kin-
dergartens, which lowered the median age of cases in 
clusters significantly (t-test p=0.004) in comparison 
with sporadic cases. 
Analysis of interviewed cases
Detailed investigation of 27 cases who were inter-
viewed revealed that the median duration of illness 
was 18 days (range: 4–84 days); 13 judged the severity 
of the disease as high or very high (Table 2). 
A majority (n=16) of the 27 interviewed cases wore 
either glasses or contact lenses. Among the inter-
viewees, 21 were not aware of any contact with other 
affected persons. In the two weeks before onset of 
symptoms, excursions to public places were reported 
in 13 cases, while 12 stayed in or visited a medical 
facility (e.g. an ophthalmologist or  eye clinics), where 
mostly eye drops were administered. A total of 11 cases 
had used communal facilities associated with sport or 
leisure activities (e.g. in a swimming pool, at the sea-
side or communal showers) (Table 2). 
Discussion
Compared with the previous two years, an increase of 
notified adenovirus conjunctivitis cases of more than 
250% was seen in 2010. Given the delay in reporting, it 
is likely that case numbers will continue to rise [14]. As 
Figure 1
Geographical distribution of notified adenovirus 
conjunctivitis casesa, Germany, 2010b (n=370)
Incidence per
100,000 population
First number: number of cluster cases (n=120)







a Laboratory notifications reported to the Robert Koch Institute, 
Berlin, Germany.
b Data as of 13 October 2010. Cases with onset of symptoms on or 
after 1 January 2010 or unknown.
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notification is confined to laboratory-confirmed cases 
– thus excluding cases that are only clinically diag-
nosed – it can be assumed that not all cases of ade-
novirus conjunctivitis are captured and a bias towards 
severe cases is possible. Although it was not feasible 
to interview all notified cases, the interviewed cases 
represented a similar sample in terms of regional, sex 
and age distribution.
Our findings – showing that the majority of cases who 
were interviewed was exposed through use of com-
munity facilities, excursions to public places within 
Germany or ophthalmological treatment – are in line 
with other published investigations [15,16]. No direct 
connection with recently described outbreaks of con-
junctivitis in various countries [1-7] could be estab-
lished due to the few records of German cases with 
known relevant travel history abroad.
Table 1
Notified adenovirus conjunctivitis casesa, Germany, by Land, 2010b (n=370)
Land
All cases Cluster cases Sporadic cases
Number Incidencec Number Incidencec Number Incidencec
Baden-Wuerttemberg 23 0.2 0 0.0 23 0.2
Bavaria 45 0.4 0 0.0 45 0.4
Berlin 14 0.4 2 0.1 12 0.4
Brandenburg 13 0.5 2 0.1 11 0.4
Bremen 2 0.3 0 0.0 2 0.3
Hamburg 50 2.8 29 1.6 21 1.2
Hesse 3 0.1 0 0.0 3 0.1
Lower Saxony 24 0.3 4 0.1 20 0.3
Mecklenburg-West-Pomerania 81 4.9 50 3.0 31 1.9
North Rhine-Westphalia 12 0.1 0 0.0 12 0.1
Rhineland-Palatinate 12 0.3 0 0.0 12 0.3
Saarland 4 0.4 0 0.0 4 0.4
Saxony 13 0.3 5 0.1 8 0.2
Saxony-Anhalt 38 1.6 26 1.1 12 0.5
Schleswig-Holstein 24 0.9 2 0.1 22 0.8
Thuringia 12 0.5 0 0.0 12 0.5
Total 370 0.5 120 0.2 250 0.3
a Laboratory notifications reported to the Robert Koch Institute, Berlin, Germany.
b Data as of 13 October 2010. Cases with onset of symptoms on or after 1 January 2010 or unknown.
c Per 100,000 population.
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The number of cases in weeks 38–40 was underreported due to reporting delay.
a Laboratory notifications reported to the Robert Koch Institute, Berlin, Germany.
b Data as of 13 October 2010. Date of symptom onset on or after 1 January 2010 was recorded for 303 cases.
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In conclusion, the analysis did not show a dispropor-
tionally affected sex or age group, except for outbreaks 
in child day-care centres and kindergartens [17]. The 
cause of the increase of notified cases in the country 
is still unclear, although the majority of infections in 
clusters was nosocomial. Information about the recent 
epidemiological developments regarding adenovirus 
conjunctivitis was shared with German ophthalmolo-
gists, with a request to submit conjunctival samples 
from patients with acute conjunctivitis to the national 
reference laboratory for serotyping. Improved hygiene 
measures are recommended, especially in ophthalmo-
logical centres [8,9]. It would be interesting to know 
if the increase seen in Germany in the number and 
severity of cases of adenovirus conjunctivitis is also 
seen in other European countries.
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Table 2
Description of interviewed adenovirus conjunctivitis 
cases, Germany, 2010a (n=27)
Description Number of casesb
Male / female / not recorded 10 / 9 / 8
Median age (range) 51 years (2–79 years)
Optical aid usedc 16 (15 with glasses, 2 with contact lenses)









Visit to or stay in a medical facilityc,d 12
Ophthalmologist 7
Eye clinic 4 (3 outpatients, 1 hospitalised)
Hospital visit 1
Optician or other medical professional 
or facility 0
Excursiond (musical, adventure park, 




Contact with other people with similar 
symptomsd 6
Visit to communal facilityd (e.g. 
swimming pool or pond, communal 
showers, sea, fitness club, sauna)
11
Use of eye cosmetics or medical 
products for eyesd 7
Use of optical instruments (e.g. 
binoculars, camera, 3D-glasses)d 6
Sharing of facecloths or towels with 
othersd 5
a Data as of 13 October 2010. Cases with onset of symptoms on or 
after 1 January 2010 or unknown.
b Unless otherwise stated.
c Multiple answers allowed.
d In the two weeks before symptom onset.
